
S230: HUMAN ΒETA‐DEFENSIN 2 TREATMENT MODULATES THE INTESTINAL MICROBIOME AND THE ALLOGENEIC T CELL RESPONSE TO LIMIT ACUTE GRAFT‐VERSUS‐HOST DISEASE
Author(s) -
Rückert T.,
Andrieux G.,
Boerries M.,
Woessner N. M.,
Minguet S.,
Doetsch S.,
Aumann K.,
Schiff M,
Braun L. M.,
Haring E.,
Siranosian B. A.,
Bhatt A. S.,
Nordkild P.,
Wehkamp J.,
Jensen B. A. H.,
Duyster J.,
Zeiser R.,
Köhler N.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843812.88278.bd
Subject(s) - graft versus host disease , immunology , beta defensin , hematopoietic stem cell transplantation , defensin , medicine , transplantation , immune system , disease , haematopoiesis , biology , stem cell , innate immune system , antimicrobial , microbiology and biotechnology , genetics